Mutual of America Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-23,346
Closed -$537K 1663
2021
Q3
$537K Sell
23,346
-336
-1% -$10K 0.01% 1102
2021
Q2
$1.04M Sell
23,682
-1,019
-4% -$56.8K 0.01% 1085
2021
Q1
$1.79M Sell
24,701
-1,367
-5% -$97.1K 0.02% 998
2020
Q4
$1.13M Buy
26,068
+9,427
+57% +$422K 0.01% 1041
2020
Q3
$684K Buy
16,641
+905
+6% +$46.8K 0.01% 1081
2020
Q2
$944K Buy
15,736
+8,015
+104% +$734K 0.01% 1051
2020
Q1
$581K Sell
7,721
-339
-4% -$39K 0.01% 1070
2019
Q4
$1.11M Buy
+8,060
New +$980K 0.01% 1070

Other funds holding ORTX

Mutual of America Capital Management's ORTX Position: Q4 2021 in Review

Mutual of America Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 23,346 shares — an estimated $537K sold.

Mutual of America Capital Management first reported a position in ORTX in Q4 2019 and held it in 8 quarters. The position peaked at $1.79M in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

  • Mutual of America Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
  • Mutual of America Capital Management sold 23,346 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $537K.
  • Mutual of America Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2019 and held it in 8 quarters.
  • Mutual of America Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $1.79M in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Mutual of America Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.